Estatísticas para NT 2384 - 2021 - eylia (aflibercepte) ou lucentis (ranizumabe) - retinopatia diabética com edema macular diabético - NATJUS TJMG
Total de visitas
| views | |
|---|---|
| NT 2384 - 2021 - eylia (aflibercepte) ou lucentis (ranizumabe) - retinopatia diabética com edema macular diabético - NATJUS TJMG | 1 |
Total visitas por mês
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
Visitas Arquivos
| views | |
|---|---|
| NT 2021.0002384 - EMD.pdf | 3 |